AtaiBeckley (ATAI) Reports 2025 Results and Q2 2026 Phase 3 Launch for BPL-003

AtaiBeckley Inc. (NASDAQ:ATAI) is 1 of the best caller penny stocks to buy. On March 6, AtaiBeckley reported full-year 2025 earnings, which were highlighted by the pivotal execution signifier pursuing the strategical operation of Atai Life Sciences and Beckley Psytech and its consequent US redomiciliation. A superior absorption is the BPL-003 nasal spray for treatment-resistant depression/TR, which is connected way to initiate a Phase 3 pivotal programme successful Q2 2026. This program, supported by the FDA, volition see 2 large studies, ReConnection-1 and ReConnection-2, with topline results anticipated by aboriginal 2029.

The institution besides reported affirmative objective advancement crossed its broader pipeline, including the VLS-01 buccal movie and EMP-01 for Social Anxiety Disorder/SAD. VLS-01 is expected to output Phase 2 topline information successful H2 2026. Meanwhile, an exploratory Phase 2a proceedings of EMP-01 successfully met its superior information objectives and showed clinically meaningful improvements successful efficacy measures. To support these innovations, AtaiBeckley secured a caller US patent for EMP-01, extending its expected exclusivity done 2043.

Copyright: nexusplexus / 123RF Stock Photo

AtaiBeckley Inc. (NASDAQ:ATAI) ended 2025 with $220.7 cardinal successful cash, currency equivalents, and short-term securities driven by equity-related issuances. While the institution reported a nett nonaccomplishment of $660 cardinal for the afloat year, mostly owed to a $530 cardinal non-cash complaint related to the Beckley Psytech acquisition, it maintains a beardown superior position. Management expects existent liquidity to money operations into aboriginal 2029, covering the timeline for its large Phase 3 readouts.

AtaiBeckley Inc. (NASDAQ:ATAI) is simply a clinical-stage biopharmaceutical institution that researches, develops, and commercializes intelligence wellness treatments successful the US, Germany, and Canada.

While we admit the imaginable of ATAI arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 40 Most Popular Stocks Among Hedge Funds Heading Into 2026 and Goldman Sachs Value Stocks: 10 Stocks to Buy.

Disclosure: None. Follow Insider Monkey connected Google News.